National Black Church Initiative: Help Shape the Future of Sickle Cell Disease

National Black Church Initiative - www.naltblackchurch.comHelp Shape the Future
of Sickle Cell Disease
Enrollment for the Global Blood Therapeutics (GBT) HOPE Study, a Phase 3 clinical research study, is underway.
The GBT HOPE study is evaluating the safety and effectiveness of Voxelotor (previously GBT440) as an oral, once-daily therapy for patients with sickle cell disease.

If you or someone you know lives with SCD, you may know the effects can span generations.

Clinical research studies are essential to help researchers learn more about future treatments for people with SCD. You or someone you know can be part of this critical research by participating in the GBT HOPE clinical study.

For more information on Voxelotor or the HOPE study, visit gbt.com or GBTsicklecellstudy.com.
Family, mother, father and son
What is the investigational medication?
The investigational medication is taken by mouth each day and designed to keep hemoglobin molecules in red blood cells from sticking to each other. This may help red blood cells keep their normal shape and stop sickling.
GBT440 binding to blood cells
GBT440 binds to red blood cells, preventing sickling and allowing them to travel normally through blood vessels
What is the purpose of the GBT HOPE study?
The GBT HOPE study will evaluate whether an investigational medication is safe and effective in reducing anemia, pain crises, fatigue, and other day-to-day symptoms in adolescents and adults with SCD.

Who can participate in the GBT HOPE study?
To qualify for the GBT HOPE study, one must:
  • Be between 12 and 65 years of age
  • Be diagnosed with SCD
  • Have had at least one pain crisis in the past year
The study doctor and staff will explain other requirements for participation.

If interested in participating in the HOPE study, contact Natalie Bongiorno at the Center for Cancer and Blood Disorders via phone at 301-571-2016 or email at nbongiorno@ccbdmd.com
GBT Sickle Cell Disease Clinical Study
CLICK HERE to "Like" NBCI on   
Facebook
About NBCI
The National Black Church Initiative (NBCI) is a coalition of 34,000 African American and Latino churches working to eradicate racial disparities in healthcare, technology, education, housing, and the environment. NBCI's mission is to provide critical wellness information to all of its members, congregants, churches and the public. The National Black Church Initiative's methodology is utilizing faith and sound health science. Visit our website at www.naltblackchurch.com.
National Black Church Initiative © 2017
Privacy Policy

Comments